Search
Cartesian Therapeutics Inc
RNACAdd to Watchlist
8.335USD
-0.355-4.08%
Market hours 09/10, 13:51（ET）
250.37MMarket Cap
LossP/E TTM
RNAC Financials
See Cartesian Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
250.37M
Dividend TTM
0.00
P/E TTM
-1.44
EPS TTM
-5.79
Revenue
2.80M
Net Profit
-77.42M
ROE
-924.61%
ROA
-43.52%
Cartesian Therapeutics Inc Earnings Date
Latest Release
Aug 6, 2026
EPS / Forecast
0.47/-0.87
Revenue / Forecast
0.00/134.75K
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2025 earnings report, its total revenue reached 2.80M, with a year-on-year change of 38.91M.
What are the current assets of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2025 earnings report, its current assets were 129.28M, with a year-on-year change of -40.32.
What are the total assets of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2025 earnings report, its total assets of Cartesian Therapeutics Inc were 296.41M, with a year-on-year change of -31.86.
What are the total liabilities of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2025 earnings report, its total liabilities of Cartesian Therapeutics Inc were 422.65M, with a year-on-year change of -4.34.
What is the total equity of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2025 earnings report, its total equity of Cartesian Therapeutics Inc was -126.24M, with a year-on-year change of -1755.92.
What is the net operating income of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2025 earnings report, its net operating income of Cartesian Therapeutics Inc was -86.70M, with a year-on-year change of -138.74.
What is the net investment of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2025 earnings report, its net investment of Cartesian Therapeutics Inc was -5.45M, with a year-on-year change of 37.61.
What is the net financing of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2025 earnings report, its net financing of Cartesian Therapeutics Inc was -8.05M, with a year-on-year change of -104.78.
What is the Earnings Per Share (EPS) of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -5.02, with a year-on-year change of -11.95.
What is the net income of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2025 earnings report, its net income was -130.30M, with a year-on-year change of -68.30.
What is the net margin of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2025 earnings report, its net profit margin was -4658.63, with a year-on-year change of -2241.41.
What is the Return on Assets (ROA) of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -35.63, with a year-on-year change of -70.28.
What is the operating profit of Cartesian Therapeutics Inc?
According to Cartesian Therapeutics Inc's FY2025 earnings report, its operating profit was -86.70M, with a year-on-year change of -138.74.